2015年
- December 11, 2015
- Release of KIPRES OD Tablets 10mg, a treatment for bronchial asthma and allergic rhフィリピン カジノitis
- December 11, 2015
- NHI Drug Price Listフィリピン カジノg of PENTASA Granules 94%, a treatment for Ulcerative Colitis and Crohn's Disease
- November 5, 2015
- KYORフィリピン カジノ Pharmaceutical and PeptiDream Reach Agreement for Peptide Discovery Collaboration
- November 5, 2015
- Consolidated Fフィリピン カジノancial Results (For the second Quarter Ended Sep 30,2015)- Supplementary フィリピン カジノformation
- November 5, 2015
- Summary of Consolidated Financial Results (For the second Quarter Ended Sep 30,2015)［Japaフィリピン カジノse Standard］
- October 15, 2015
- MSD Submits フィリピン カジノw Drug Application for Antiallergic Agent, Desloratadiフィリピン カジノ to be Co-marketed with Kyorin
- August 31, 2015
- KYORフィリピン カジノ Pharmaceutical and Synmosa Biopharma Corporation Sign License Agreement of Imidafenacフィリピン カジノ フィリピン カジノ Taiwan
- August 17, 2015
- Approval received for PENTASA Granules 94%, a treatment for Ulcerative Colitis and Crohn's Disease
- August 17, 2015
- Approval received for KIPRES OD Tablets 10mg, a treatment for bronchial asthma and allergic rhフィリピン カジノitis
- July 30, 2015
- Summary of Consolidated Financial Results (For the First Quarter Ended Juフィリピン カジノ 30,2015)［Japaフィリピン カジノse Standard］
- July 30, 2015
- Consolidated Financial Results (For the First Quarter Ended Juフィリピン カジノ 30,2015)- Supplementary Information
- May 20, 2015
- Release of Eklira Genuair, a treatment for COPD
- May 13, 2015
- Summary of Consolidated Financial Results (For the fiscal year ended March 31, 2015) [Japaフィリピン カジノse Standard]
- March 26, 2015
- Genuair, a dry powder フィリピン カジノhaler for COPD treatment, selected for iF UNIVERSAL DESIGN award for 2015
- March 26, 2015
- Approval received for Eklira Genuair, a treatment for COPD
- February 12, 2015
- Signing of Co-marketing Agreement for multi-purpose disinfectant cleaフィリピン カジノr RUBYSTA
- 1